MDx Firm Akonni Biosystems Seeks to Raise $8M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Akonni Biosystems is seeking to raise $8 million, it disclosed in a document filed on Monday with the US Securities and Exchange Commission.

In its filing, the Frederick, Md.-based firm said it has raised $912,598 in the private round of financing so far. It did not say how the funds will be used but said the offering is not being made in connection with a merger, acquisition or exchange offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.